Neurocrine Biosciences (NBIX) Return on Assets [ROA] (2011 - 2026)
Neurocrine Biosciences' Return on Assets [ROA] was 13.75% in Q2 2026, up 4.55 percentage points from 9.19% a year earlier but down 0.27 percentage points from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Return on Assets [ROA] (2011 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at Neurocrine Biosciences came in at 11.46%, up 1.67 percentage points from FY2024.
- Return on Assets [ROA] has now increased for four consecutive years, though with a five-year change of -15.33 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was 9.79% in FY2024 (+0.91 pp), 8.89% in FY2023 (+1.93 pp), 6.96% in FY2022 (+2.25 pp) and 4.71% in FY2021 (-22.08 pp).
- Quarterly Return on Assets [ROA] has moved between 0.59% (Q2 2022) and 22.39% (Q3 2021) over five years.
- Compared with a year earlier, Return on Assets [ROA] has increased for three straight quarters, with an average year-over-year change of +1.60 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q3 2021 (a gain of 16.20 percentage points); the worst was Q4 2021 (a drop of 20.78 percentage points).
- Per Business Quant data, NBIX's Return on Assets [ROA] in the three quarters before Q2 2026 was 14.02% (Q1 2026), 10.76% (Q4 2025) and 10.50% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Neurocrine Biosciences | 14.41 Bn | 10.11 Bn | 935.80 Mn | 13.75% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.75% |
| Mar 31, 2026 | 14.02% |
| Dec 31, 2025 | 10.76% |
| Sep 30, 2025 | 10.50% |
| Jun 30, 2025 | 9.19% |
| Mar 31, 2025 | 8.26% |
| Dec 31, 2024 | 9.41% |
| Sep 30, 2024 | 11.28% |
| Jun 30, 2024 | 10.01% |
| Mar 31, 2024 | 11.00% |
| Dec 31, 2023 | 8.19% |
| Sep 30, 2023 | 6.99% |
| Jun 30, 2023 | 7.09% |
| Mar 31, 2023 | 2.71% |
| Dec 31, 2022 | 6.85% |
| Sep 30, 2022 | 2.81% |
| Jun 30, 2022 | 0.59% |
| Mar 31, 2022 | 3.39% |
| Dec 31, 2021 | 4.38% |
| Sep 30, 2021 | 22.39% |
API Access
Neurocrine Biosciences Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();